Hyperbaric oxygen treatment (HBO2) is recognized as a valuable adjunct therapy for numerous health conditions characterized by compromised tissue blood flow. Its list of indications continues to expand alongside our increasing understanding of its mechanisms of action. For instance, in August 2013, the US Food and Drug Administration designated artery occlusion as one of the specific indications for HBO therapy.